Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases ; volume:10 ; number:1 ; day:6 ; month:11 ; year:2017 ; pages:1-9 ; date:12.2017
BMC Research Notes / Biomed Central; 10, Heft 1 (6.11.2017), 1-9, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Rausch, Valentin
- Beteiligte Personen und Organisationen
-
Krieg, Andreas
Camps, Jordi
Behrens, Bianca
Beier, Manfred
Wangsa, Darawalee
Heselmeyer-Haddad, Kerstin
Baldus, Stephan E.
Knoefel, Wolfram T.
Ried, Thomas
Stoecklein, Nikolas H.
SpringerLink (Online service)
- DOI
-
10.1186/s13104-017-2886-0
- URN
-
urn:nbn:de:1111-201801044005
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rausch, Valentin
- Krieg, Andreas
- Camps, Jordi
- Behrens, Bianca
- Beier, Manfred
- Wangsa, Darawalee
- Heselmeyer-Haddad, Kerstin
- Baldus, Stephan E.
- Knoefel, Wolfram T.
- Ried, Thomas
- Stoecklein, Nikolas H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning
Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas
Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
Novel molecular insights to discern and target migrating cancer stem cells in pancreatic ductal adenocarcinomas
DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases
rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses
HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis
Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas
Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas
Proteome profiling of primary pancreatic ductal adenocarcinomas undergoing additive chemoradiation link ALDH1A1 to early local recurrence and chemoradiation resistance
Hybridization.
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning
Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas
Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
Novel molecular insights to discern and target migrating cancer stem cells in pancreatic ductal adenocarcinomas
DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases
rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses
HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis
Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas
Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas
Proteome profiling of primary pancreatic ductal adenocarcinomas undergoing additive chemoradiation link ALDH1A1 to early local recurrence and chemoradiation resistance
Hybridization.
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning
Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas
Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
Novel molecular insights to discern and target migrating cancer stem cells in pancreatic ductal adenocarcinomas
DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases
rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses
HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis
Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas
Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas
Proteome profiling of primary pancreatic ductal adenocarcinomas undergoing additive chemoradiation link ALDH1A1 to early local recurrence and chemoradiation resistance